Biosensors and Bioelectronics,
Journal Year:
2023,
Volume and Issue:
231, P. 115271 - 115271
Published: March 31, 2023
Current
in-vitro
2D
cultures
and
animal
models
present
severe
limitations
in
recapitulating
human
physiopathology
with
striking
discrepancies
estimating
drug
efficacy
side
effects
when
compared
to
trials.
For
these
reasons,
microphysiological
systems,
organ-on-chip
multiorgans
microdevices
attracted
considerable
attention
as
novel
tools
for
high-throughput
high-content
research
achieve
an
improved
understanding
of
diseases
accelerate
the
development
process
towards
more
precise
eventually
personalized
standards.
This
review
takes
form
a
guide
on
this
fast-growing
field,
providing
useful
introduction
major
themes
indications
further
readings.
We
start
analyzing
Organs-on-chips
(OOC)
technologies
testing
administration
routes:
(1)
oral/rectal
route
by
intestine-on-a-chip,
(2)
inhalation
lung-on-a-chip,
(3)
transdermal
skin-on-a-chip
(4)
intravenous
through
vascularization
models,
considering
how
drugs
penetrate
bloodstream
are
conveyed
their
targets.
Then,
we
focus
OOC
(other)
specific
organs
diseases:
neurodegenerative
brain
blood
barriers,
tumor
including
vascularization,
organoids/spheroids,
engineering
screening
antitumor
drugs,
liver/kidney
chips
multiorgan
gastrointestinal
metabolic
assessment
biomechanical
systems
heart,
muscles
bones
structures
related
diseases.
Successively,
discuss
materials
organ
chips,
microfluidic
organs-on-chips,
sensor
integration
real-time
monitoring,
cell
lines
chips.
(Nano)delivery
approaches
therapeutics
chip
also
described.
Finally,
conclude
critical
discussion
current
significance/relevance,
trends,
limitations,
challenges
future
prospects
terms
revolutionary
impact
biomedical
research,
preclinical
development.
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(13), P. 4526 - 4558
Published: Jan. 1, 2023
Drug
evaluation
has
always
been
an
important
area
of
research
in
the
pharmaceutical
industry.
However,
animal
welfare
protection
and
other
shortcomings
traditional
drug
development
models
pose
obstacles
challenges
to
evaluation.
Organ-on-a-chip
(OoC)
technology,
which
simulates
human
organs
on
a
chip
physiological
environment
functionality,
with
high
fidelity
reproduction
organ-level
physiology
or
pathophysiology,
exhibits
great
promise
for
innovating
pipeline.
Meanwhile,
advancement
artificial
intelligence
(AI)
provides
more
improvements
design
data
processing
OoCs.
Here,
we
review
current
progress
that
made
generate
OoC
platforms,
how
single
multi-OoCs
have
used
applications,
including
testing,
disease
modeling,
personalized
medicine.
Moreover,
discuss
issues
facing
field,
such
as
large
reproducibility,
point
integration
OoCs
AI
analysis
automation,
is
benefit
future
Finally,
look
forward
opportunities
faced
by
coupling
AI.
In
summary,
advancements
development,
combinations
AI,
will
eventually
break
state
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(32), P. 20957 - 20979
Published: Aug. 1, 2024
Multifunctional
micro-/nanomaterials
featuring
functional
superiority
and
high
value-added
physicochemical
nature
have
received
immense
attention
in
electrochemical
energy
storage.
Microfluidic
synthesis
has
become
an
emergent
technology
for
massively
producing
multifunctional
with
tunable
microstructure
morphology
due
to
its
rapid
mass/heat
transfer
precise
fluid
controllability.
In
this
review,
the
latest
progresses
achievements
microfluidic-synthesized
are
summarized
via
reaction
process
intensification,
micro-/nanostructural
engineering
storage
applications.
The
intensification
mechanisms
of
various
micro-/nanomaterials,
including
quantum
dots
(QDs),
metal
materials,
conducting
polymers,
metallic
oxides,
polyanionic
compounds,
metal–organic
frameworks
(MOFs)
two-dimensional
(2D)
discussed.
Especially,
structural
principles
as-fabricated
such
as
vertically
aligned
structure,
heterostructure,
core–shell
microsphere,
introduced.
Subsequently,
application
as-prepared
is
clarified
supercapacitors,
lithium-ion
batteries,
sodium-ion
all-vanadium
redox
flow
dielectric
capacitors.
Finally,
current
problems
future
forecasts
illustrated.
Advanced Science,
Journal Year:
2021,
Volume and Issue:
8(19)
Published: Aug. 5, 2021
Abstract
Vascularization
of
3D
models
represents
a
major
challenge
tissue
engineering
and
key
prerequisite
for
their
clinical
industrial
application.
The
use
prevascularized
built
from
dedicated
materials
could
solve
some
the
actual
limitations,
such
as
suboptimal
integration
bioconstructs
within
host
tissue,
would
provide
more
in
vivo‐like
perfusable
organ‐specific
platforms.
In
last
decade,
fabrication
vascularized
physiologically
relevant
constructs
has
been
attempted
by
numerous
strategies,
which
are
classified
here
microfluidic
technology,
coculture
models,
namely,
spheroids
organoids,
biofabrication.
this
review,
recent
advancements
prevascularization
techniques
increasing
natural
synthetic
to
build
physiological
discussed.
Current
drawbacks
each
future
perspectives,
translation
toward
clinics,
pharmaceutical
field,
industry
also
presented.
By
combining
complementary
these
envisioned
be
successfully
used
regenerative
medicine
drug
development
near
future.
Materials Horizons,
Journal Year:
2023,
Volume and Issue:
10(7), P. 2343 - 2372
Published: Jan. 1, 2023
Layout
structure
of
this
review.
Highlighting
the
fabrication,
design
principles
and
applications
microreactors
for
synthesis
inorganic,
organic
composite
micro/nanomaterials.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 3836 - 3836
Published: March 29, 2024
Presently,
millions
worldwide
suffer
from
degenerative
and
inflammatory
bone
joint
issues,
comprising
roughly
half
of
chronic
ailments
in
those
over
50,
leading
to
prolonged
discomfort
physical
limitations.
These
conditions
become
more
prevalent
with
age
lifestyle
factors,
escalating
due
the
growing
elderly
populace.
Addressing
these
challenges
often
entails
surgical
interventions
utilizing
implants
or
grafts,
though
treatments
may
entail
complications
such
as
pain
tissue
death
at
donor
sites
for
along
immune
rejection.
To
surmount
challenges,
engineering
has
emerged
a
promising
avenue
injury
repair
reconstruction.
It
involves
use
different
biomaterials
development
three-dimensional
porous
matrices
scaffolds,
alongside
osteoprogenitor
cells
growth
factors
stimulate
natural
regeneration.
This
review
compiles
methodologies
that
can
be
used
develop
are
important
replacement
Biomaterials
orthopedic
implants,
several
scaffold
types
production
methods,
well
techniques
assess
biomaterials’
suitability
human
use—both
laboratory
settings
within
living
organisms—are
discussed.
Even
researchers
have
had
some
success,
there
is
still
room
improvements
their
processing
techniques,
especially
ones
make
scaffolds
mechanically
stronger
without
weakening
biological
characteristics.
Bone
therefore
area
rise
bone-related
injuries.
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(5), P. 1982 - 2035
Published: Jan. 1, 2024
Many
human
tissues
exhibit
a
highly
oriented
architecture
that
confers
them
with
distinct
mechanical
properties,
enabling
adaptation
to
diverse
and
challenging
environments.
Hydrogels,
their
water-rich
"soft
wet"
structure,
have
emerged
as
promising
biomimetic
materials
in
tissue
engineering
for
repairing
replacing
damaged
organs.
Highly
hydrogels
can
especially
emulate
the
structural
orientation
found
tissue,
exhibiting
unique
physiological
functions
properties
absent
traditional
homogeneous
isotropic
hydrogels.
The
design
preparation
of
involve
strategies
like
including
nanofillers,
polymer-chain
networks,
void
channels,
microfabricated
structures.
Understanding
specific
mechanism
action
how
these
affect
cell
behavior
biological
applications
such
cornea,
skin,
skeletal
muscle,
tendon,
ligament,
cartilage,
bone,
blood
vessels,
heart,
etc.,
requires
further
exploration
generalization.
Therefore,
this
review
aims
fill
gap
by
focusing
on
strategy
application
field
engineering.
Furthermore,
we
provide
detailed
discussion
various
organs
mechanisms
through
which
structures
influence
behavior.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(23), P. 14582 - 14582
Published: Nov. 23, 2022
The
discrepancies
between
the
findings
in
preclinical
studies,
and
vivo
testing
clinical
trials
have
resulted
gradual
decline
drug
approval
rates
over
past
decades.
Conventional
vitro
screening
platforms
employ
two-dimensional
(2D)
cell
culture
models,
which
demonstrate
inaccurate
responses
by
failing
to
capture
three-dimensional
(3D)
tissue
microenvironment
vivo.
Recent
advancements
field
of
engineering
made
possible
creation
3D
systems
that
can
accurately
recapitulate
cell–cell
cell–extracellular
matrix
interactions,
as
well
replicate
intricate
microarchitectures
observed
native
tissues.
However,
lack
a
perfusion
system
cultures
hinders
establishment
models
potential
platforms.
Over
years,
multiple
techniques
successfully
demonstrated
vascularization
cultures,
simulating
vivo-like
proposing
use
eliminate
deviations
testing.
In
this
review,
basic
principles
are
briefly
introduced,
current
research
demonstrating
development
is
discussed,
with
particular
focus
on
these
future
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2022,
Volume and Issue:
10
Published: March 14, 2022
Human
Microphysiological
Systems
(hMPS),
otherwise
known
as
organ-
and
tissue-on-a-chip
models,
are
an
emerging
technology
with
the
potential
to
replace
in
vivo
animal
studies
vitro
models
that
emulate
human
physiology
at
basic
levels.
hMPS
platforms
designed
overcome
limitations
of
two-dimensional
(2D)
cell
culture
systems
by
mimicking
3D
tissue
organization
microenvironmental
cues
physiologically
clinically
relevant.
Unlike
studies,
can
be
configured
for
high
content
or
throughput
screening
preclinical
drug
development.
Applications
modeling
acute
chronic
injuries
musculoskeletal
system
slowly
developing.
However,
complexity
load
bearing
nature
tissues
joints
present
unique
challenges
related
our
limited
understanding
disease
mechanisms
lack
consensus
biomarkers
guide
biological
therapy
With
emphasis
on
examples
tissues,
chips,
organoids,
this
review
highlights
current
trends
microphysiological
technology.
The
surveys
state-of-the-art
design
fabrication
considerations
inspired
lessons
from
bioreactors
variables
emphasizing
role
induced
pluripotent
stem
cells
genetic
engineering
creating
isogenic,
patient-specific
multicellular
hMPS.
major
using
chips
identified,
including
incorporating
barriers,
simulating
joint
compartments
heterogenous
interfaces,
immune
interactions
inflammatory
factors,
effects
loading,
recording
nociceptors
responses
surrogates
pain
outcomes,
dynamic
injury
healing
monitoring
secreted
proteins
real
time,
arrayed
formats
robotic
screens.
Overcoming
these
barriers
will
revolutionize
research
enabling
relevant,
predictive
diseases
accelerate
de-risk
therapeutic
discovery
translation
clinic.
Proceedings of the National Academy of Sciences,
Journal Year:
2022,
Volume and Issue:
119(35)
Published: Aug. 24, 2022
The
next
robotics
frontier
will
be
led
by
biohybrids.
Capable
biohybrid
robots
require
microfluidics
to
sustain,
improve,
and
scale
the
architectural
complexity
of
their
core
ingredient:
biological
tissues.
Advances
in
have
already
revolutionized
disease
modeling
drug
development,
are
positioned
impact
regenerative
medicine
but
yet
apply
Fusing
with
living
materials
improve
tissue
perfusion
maturation,
enable
precise
patterning
sensing,
processing,
control
elements.
This
perspective
suggests
future
developments
advanced